Adaptive ventricular rate smoothing during atrial fibrillation: a pilot comparison study

Area of Science:

• Biomedical Engineering
• Computational Cardiology
• Medical Devices

Background:

• Atrial fibrillation (AF) often leads to irregular and rapid ventricular rates.
• Ventricular pacing (VP) can regularize heart rate, but effective algorithms are needed.
• Existing ventricular rate smoothing (VRS) algorithms have limitations in managing AF-induced rate variability.

Purpose of the Study:

• To develop and evaluate an adaptive ventricular rate smoothing (VRS) algorithm for regularizing ventricular rate during AF.
• To compare the performance of the adaptive-VRS algorithm against existing VRS methods using a quantitative AF-VP model.
• To assess the algorithm's ability to minimize ventricular pacing while preserving physiological heart rate and rhythm.

Main Methods:

• Development of a novel adaptive VRS algorithm.
• Utilization of a quantitative atrial fibrillation and ventricular pacing (AF-VP) model for simulations.
• Comparative analysis of the adaptive-VRS algorithm with three other VRS algorithms.
• Pilot study simulations to assess algorithm performance under varying intrinsic ventricular rates.

Main Results:

• All tested VRS algorithms effectively stabilized ventricular rate during AF when the intrinsic rate was below the maximum pacing rate.
• The efficacy of VRS diminished with increasing intrinsic ventricular rates.
• Slower intrinsic ventricular rates resulted in more aggressive VP across all algorithms.
• The adaptive-VRS algorithm demonstrated superior performance by stabilizing the ventricular rate with reduced VP compared to other methods.
• The adaptive-VRS algorithm better preserved physiological rate and rhythm during AF.

Conclusions:

• The developed adaptive-VRS algorithm offers an effective approach to manage ventricular rate during AF.
• This adaptive algorithm provides improved rate stabilization with less ventricular pacing, enhancing patient outcomes.
• The adaptive-VRS algorithm shows promise for preserving natural cardiac function during AF management.